๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial

โœ Scribed by Robert O. Dillman; Neil M. Barth; Robert K. Oldham; Richard J. Cohen; David R. Minor; Robert Birch; Jerri Arnold; John R. Yannelli; James R. Maleckar; Anthony Sferruzza; William H. West

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
798 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A randomized trial of adoptive immunothe
A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer
โœ Giovanni B. Ratto; Paolo Zino; Sandro Mirabelli; Paolo Minuti; Riccardo Aquilina ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 750 KB

A previous pilot study from our group suggested that: (1) adoptive immunotherapy (AI) with tumor-infiltrating lymphocytes (TIL) and recombinant interleukin-2 (rIL-2) may be applied with safety to more than 80% of the patients who had surgery for Stage 111 nonsmall cell lung carcinoma (NSCLC); and (2

Peptide-specific ctl in tumor-infiltrati
Peptide-specific ctl in tumor-infiltrating lymphocytes from metastatic melanomas expressing mart-1/melan-a, gp100 and tyrosinase genes: A study in an unselected group of hla-a2.1-positive patients
โœ Giulio C. Spagnoli; Christoph Schaefer; Thomas E. Willimann; Thomas Kocher; Anto ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 935 KB

Peptide specificity of cultured tumor-infiltrating lymphocytes (TIL) was systematically investigated in a group of HLA-A2. I + metastatic melanoma patients consecutively referred to our department for surgical treatment. Seven samples from 6 patients were studied. All surgical specimens showed evide